PT
Pliant Therapeutics Inc
🇺🇸XNAS.PLRXUnited StatesHealthcare
$1.13USDunchanged 0.00 (0%)OpenDelayed5:38 PM
Price$1.130.00 (0%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US7291391057
- CUSIP
- 727049405
Company
- Employees
- 49
- Headquarters
- South San Francisco, United States
- Website
- https://pliantrx.com
- CEO
- Dr. Bernard Coulie M.B.A., M.D., Ph.D.
Market
- Shares outstanding
- 61.9M
- Market cap
- $69.97M
Key dates
- Next earnings
- Nov 5, 2026
Highlights
- Market cap
- $69.97M
- EPS LTM
- -$1.49
- P/E LTM
- -0.78
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $0-100%down year on year
- Net income
- -$92.29M+55.41%up year on year
- Gross margin
- Not reported
- Free cash flow
- -$70.9M+58.51%up year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.